Please login to the form below

Not currently logged in
Email:
Password:

cholesterol

This page shows the latest cholesterol news and features for those working in and with pharma, biotech and healthcare.

US court backs Sanofi/Regeneron in PCSK9 patent dispute with Amgen

US court backs Sanofi/Regeneron in PCSK9 patent dispute with Amgen

patent rights to their PCSK9 inhibitor cholesterol drugs. ... Sanofi/Regeneron and Amgen are expecting the drugs to gather momentum now that they have cardiovascular outcomes data to go along with surrogate results based on LDL cholesterol, although

Latest news

More from news
Approximately 23 fully matching, plus 454 partially matching documents found.

Latest Intelligence

  • A roadmap to the successful treatment of Alzheimer’s disease A roadmap to the successful treatment of Alzheimer’s disease

    This would create a similar situation to cardiovascular disease where we use cholesterol as a biomarker and give statins in a preventative mode.

  • AstraZeneca: building a new ‘open innovation’ pharma company AstraZeneca: building a new ‘open innovation’ pharma company

    All of these new drugs are helping the company overcome the decline of its cholesterol drug Crestor.

  • Tools for the digital world Tools for the digital world

    One study showed that patients with uncontrolled hypertension and diabetes achieved significantly greater reduction in blood pressure (BP) and LDL cholesterol, and were more likely to reach their BP goal, than

  • Challenging times Challenging times

    continents. We surveyed 21, 300 research participants with a range of chronic diseases including but not limited to high blood pressure, high cholesterol, diabetes, asthma, heart conditions and cancer.

  • Pharma deals in September 2015 Pharma deals in September 2015

    Amgen's busy month (part 2). Following FDA approval for its novel PCSK9 treatment for “bad cholesterol”, Amgen is moving onto tackle dyslipidemia, an asymptomatic disease in which serum lipid levels ... Dezima's TA-8995 (phase 2b-complete), is an

More from intelligence
Approximately 0 fully matching, plus 15 partially matching documents found.

Latest appointments

More from appointments
Approximately 0 fully matching, plus 1 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 0 fully matching, plus 6 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Branding Science

We are Branding Science Partners in thinking which inspires change in healthcare Branding Science are an award-winning global pharmaceutical market...

Latest intelligence

Alzheimers incidence
A roadmap to the successful treatment of Alzheimer’s disease
Building on past research to learn more about the disease and how to treat it...
Article: Like, Like, Like: Harnessing the power of social media insights
...
Its Know Your Numbers week
Do you know yours?...

Infographics